- Home
- GSBC vs SGP Comparison
GSBC vs SGP Comparison
Compare GSBC & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSBC | SGP |
|---|---|---|
| Founded | 1923 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 859.1M | 968.0M |
| IPO Year | 1996 | 2026 |
Fundamental Metrics
Financial Performance| Metric | GSBC | SGP |
|---|---|---|
| Price | $78.11 | $26.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $65.00 | $45.00 |
| AVG Volume (30 Days) | 61.6K | ★ 107.0K |
| Earning Date | 04-15-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | ★ 17.68 | N/A |
| EPS | ★ 2.99 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.56 | N/A |
| P/E Ratio | $26.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $53.76 | $17.06 |
| 52 Week High | $82.91 | $30.56 |
Technical Indicators
Market Signals| Indicator | GSBC | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 41.48 | 42.32 |
| Support Level | $77.24 | $25.00 |
| Resistance Level | $82.03 | $26.29 |
| Average True Range (ATR) | 1.28 | 1.46 |
| MACD | -0.15 | -0.46 |
| Stochastic Oscillator | 8.18 | 4.37 |
Price Performance
Historical ComparisonAbout GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.